Advisory BoardWissenschaftliche Berater
    t2cure’s cell therapy is available through cooperating clinical centres
    t2cure cooperates with experienced partners in research and in the industry.
    t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
    t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.

    Advisory Board

    Prof. Dr. Andreas M. Zeiher (Founder)

    Dr. Zeiher is board-certified in internal medicine and cardiology and has served on the faculties of Albert-Ludwigs-University of Freiburg from 1990 – 1995 as director of interventional cardiology. Since 1995, Dr. Zeiher is the Chairman of Medicine in the Department of Cardiology / Nephrology at the J. W. Goethe-University of Frankfurt.

    Dr. Zeiher is the recipient of numerous awards, honors and grants and has published more than 200 articles and reviews. He is a fellow of the European Society of Cardiology. Dr. Zeiher is past-chairman of the Working Group on Interventional Cardiology of the European Society of Cardiology. He served on the editorial boards of several journals, including Circulation, Circulation Research, European Heart Journal and others.

    His research interests include basic and clinical aspects of endothelial cell function, the role of stem and progenitor cells for endogenous cardiovascular repair as well as their therapeutic application for regenerating cardiovascular function, and the use of biomarkers for risk prediction and therapeutic stratification of patients with acute coronary syndromes.